Insmed | Despesas Operacionais



Operating Expenses Alterar Data
BioMarin Pharmaceutical USD 521.25M 64.65M 2025-03
Cytokinetics USD 157.21M 1.24M 2025-03
DBV Technologies USD 31.4M 3.6M 2024-09
Dynavax Technologies USD 91.79M 18.13M 2025-03
Gilead Sciences USD 4.43B 687M 2025-03
Insmed USD 340.96M 6.11M 2025-03
Novartis USD 10.15B 579M 2024-12
Regeneron Pharmaceuticals USD 2.44B 362M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12



Insmed Despesas Operacionais - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.